Targeting NOX2 and glycolytic metabolism as a therapeutic strategy in acute myeloid leukaemia
Abstract Acute myeloid leukaemia (AML) is a highly heterogeneous malignancy, with a poor 5-year overall survival rate of approximately 30%. Consequently, the search for novel therapeutic strategies is ongoing, and the identification of new vulnerabilities could accelerate progress. Oxidative stress...
Saved in:
Main Authors: | Carla Ijurko (Author), Marta Romo-González (Author), Rodrigo Prieto-Bermejo (Author), María Díez-Campelo (Author), María-Belén Vidriales (Author), Sandra Muntión (Author), Fermín Sánchez-Guijo (Author), Jesús Sánchez-Yagüe (Author), Ángel Hernández-Hernández (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of Xanthine Oxidoreductase Enhances the Potential of Tyrosine Kinase Inhibitors against Chronic Myeloid Leukemia
by: Marta Romo-González, et al.
Published: (2020) -
The Biology and Treatment of Myeloid Leukaemias
by: Ewa Marcinkowska (Ed.)
Published: (2018) -
Exploring the acute myeloid leukaemias
by: TB Thapa
Published: (2013) -
Extramedullary Myeloid Cell Tumour Presenting As Leukaemia Cutis
by: Thappa Devinder Mohan, et al.
Published: (2002) -
Spontaneous chest wall haematoma in chronic myeloid leukaemia
by: Mohamed Dwebi, et al.
Published: (2019)